Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.

Feed excerpt — reported by MarketWatch

For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at MarketWatch →

View MAP Context →